Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028390
Filing Date
2021-05-17
Accepted
2021-05-17 16:12:59
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q annx-10q_20210331.htm 10-Q 2040393
2 EX-31.1 annx-ex311_7.htm EX-31.1 20301
3 EX-31.2 annx-ex312_8.htm EX-31.2 20233
4 EX-32.1 annx-ex321_6.htm EX-32.1 15179
  Complete submission text file 0001564590-21-028390.txt   5507500

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT annx-20210331.xml EX-101.INS 969571
6 XBRL TAXONOMY EXTENSION SCHEMA annx-20210331.xsd EX-101.SCH 32427
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE annx-20210331_cal.xml EX-101.CAL 35888
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE annx-20210331_def.xml EX-101.DEF 98843
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20210331_lab.xml EX-101.LAB 294857
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20210331_pre.xml EX-101.PRE 218534
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 21930715
SIC: 2834 Pharmaceutical Preparations